touchPODCAST

Targeting BCMA in multiple myeloma: Insights from COMy and EHA 2024

touchCONGRESS for touchONCOLOGY

Listen to multiple myeloma expert Prof. María-Victoria Mateos review key data for BCMA-targeting agents in the treatment of multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy) and European Hematology Association (EHA) 2024 congresses. Prof. Mateos is then joined by fellow experts Dr Rakesh Popat and Prof. Evangelos Terpos to discuss how these data may apply in clinical practice.

Overview

•       Data reviews with Prof. Mateos,
•       Expert panel discussions with Prof. Mateos, Dr Popat and Prof. Terpos on the themes below

Clinical themes

1. Approved indications for BCMA-targeting agents,
2. New approaches to the use of existing BCMA-targeting agents,
3. Emerging BCMA-targeting agents

The internationally renowned multiple myeloma expert faculty

•       Prof. María-Victoria Mateos: Salamanca, Spain,
•       Dr Rakesh Popat: London, UK,
•       Prof. Evangelos Terpos: Athens, Greece

This touchPODCAST is for HCPs outside of the USA and UK only.

This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider.

For further information visit our website: https://touchoncologyime.org/bcma-mm-comy-eha-2024 

Targeting BCMA in multiple myeloma: Insights from COMy and EHA 2024

touchCONGRESS for touchHAEMATOLOGY

Listen to multiple myeloma expert Prof. María-Victoria Mateos review key data for BCMA-targeting agents in the treatment of multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy) and European Hematology Association (EHA) 2024 congresses. Prof. Mateos is then joined by fellow experts Dr Rakesh Popat and Prof. Evangelos Terpos to discuss how these data may apply in clinical practice.

Overview

•       Data reviews with Prof. Mateos,
•       Expert panel discussions with Prof. Mateos, Dr Popat and Prof. Terpos on the themes below

Clinical themes

1. Approved indications for BCMA-targeting agents,
2. New approaches to the use of existing BCMA-targeting agents,
3. Emerging BCMA-targeting agents

The internationally renowned multiple myeloma expert faculty

•       Prof. María-Victoria Mateos: Salamanca, Spain,
•       Dr Rakesh Popat: London, UK,
•       Prof. Evangelos Terpos: Athens, Greece

This touchPODCAST is for HCPs outside of the USA and UK only.

This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider.

For further information visit our website: 
https://touchhaematologyime.org/bcma-mm-comy-eha-2024

Innovations in glaucoma care: Targeting pathophysiology to expand treatment options

touchEXPERT OPINIONS for touchOPHTHALMOLOGY

Listen to leading experts describe the pathophysiology of open-angle glaucoma and discuss how it is targeted by current and emerging treatment options, while providing insights on how different agents and combinations are used in practice.

The experts

• Angelo P Tanna, MD - Northwestern University Feinberg School of Medicine, Chicago, IL, USA
• Courtney E Bovee, MD - Bovee Eye, Tampa Bay, FL, USA
• Joseph F Panarelli, MD - NYU Langone Eye Center, New York, NY, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Alcon Vision, LLC and is jointly provided by USF Health and touchIME.

For further information visit our website:  https://touchOPHTHALMOLOGY.com/

Experts in dermatology discuss the latest in treating moderate-to-severe atopic dermatitis in children and adolescents

touchIN CONVERSATION for touchIMMUNOLOGY

Listen to Prof. Diamant Thaçi in conversation with Dr Benjamin Ungar. They respond to questions submitted by the HCP audience and provide their expert insights regarding managing moderate–severe atopic dermatitis (AD) in children and adolescents, including assessing the severity of AD, selecting systemic therapy, and managing the potential side effects of systemic treatment.

This touchPODCAST is for HCPs outside of the UK.

This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals and is jointly provided by USF Health and touchIME.

For further information visit our website: touchimmunology.com

Experts in dermatology discuss the latest in treating moderate-to-severe atopic dermatitis in children and adolescents

touchIN CONVERSATION for touchDERMATOLOGY

Listen to Prof. Diamant Thaçi in conversation with Dr Benjamin Ungar. They respond to questions submitted by the HCP audience and provide their expert insights regarding managing moderate–severe atopic dermatitis (AD) in children and adolescents, including assessing the severity of AD, selecting systemic therapy, and managing the potential side effects of systemic treatment.

This touchPODCAST is for HCPs outside of the UK. 

This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals and is jointly provided by USF Health and touchIME.

For further information visit our website: touchderma.com

Updates in recurrent/metastatic nasopharyngeal carcinoma: The evolving role of immune checkpoint inhibitors

touchFOCUS for touchONCOLOGY

Listen to Prof. Barbara Burtness as she answers a series of questions focused on the evolving role of immune checkpoint inhibitors  in the first- and subsequent-line settings for recurrent/metastatic nasopharyngeal carcinoma. 

The expert

Prof. Barbara Burtness, Yale School of Medicine, New Haven, CT, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Coherus BioSciences. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/touchfocus_evolving-role-of-icis-in-rm-npc/

touchMDT – A comprehensive approach to symptom care in PBC – Discussion 3 - touchENDOCRINOLOGY

touchMDT for touchENDOCRINOLOGY

Listen to experts Prof. Sonja Ständer, Ms Michelle Clayton, Prof. Gideon Hirschfield and patient advocate, Mrs Collette Thain MBE, discuss individualizing management strategies for patients with cholestatic pruritus and primary biliary cholangitis (PBC), and the importance of patient education and counselling.

The multidisciplinary team and patient advocate:

Dermatologist – Prof. Sonja Ständer
University of Münster, Münster, Germany

Nurse – Ms Michelle Clayton
St James’ University Hospital, Leeds, UK

Hepatologist – Prof. Gideon Hirschfield
University of Toronto, Toronto, Canada 

Patient Advocate – Mrs Collette Thain MBE
PBC Foundation, Edinburgh, UK

This touchPODCAST is for HCPs outside of the UK and USA only.

This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC^® accredited provider.

For further information visit our website: https://touchendocrinologyIME.org/mdt-cholestatic-pruritus-in-patients-with-pbc/

touchMDT – Symptom assessment and monitoring in clinical practice – Discussion 2 - touchENDOCRINOLOGY

touchMDT for touchENDOCRINOLOGY

Listen to experts Ms Michelle Clayton, Prof. Sonja Ständer and Prof. Gideon Hirschfield discuss the importance of assessing for cholestatic pruritus in patients with primary biliary cholangitis (PBC) and review the tools used in clinical practice.

The multidisciplinary team:

Nurse – Ms Michelle Clayton
St James’ University Hospital, Leeds, UK

Dermatologist – Prof. Sonja Ständer
University of Münster, Münster, Germany

Hepatologist – Prof. Gideon Hirschfield
University of Toronto, Toronto, Canada

This touchPODCAST is for HCPs outside of the UK and USA only.

This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC^® accredited provider.

For further information visit our website: https://touchendocrinologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/

touchMDT – Pruritus in PBC and me: The patient experience – Discussion 1 - touchENDOCRINOLOGY

touchMDT for touchENDOCRINOLOGY

Pruritus in PBC and me: The patient experience

Listen to experts Prof. Gideon Hirschfield and Prof. Sonja Ständer, plus patient advocate Mrs Collette Thain MBE, explore the burden of cholestatic pruritus in patients with primary biliary cholangitis (PBC).

The multidisciplinary team and patient advocate:

Hepatologist – Prof. Gideon Hirschfield
University of Toronto, Toronto, Canada

Dermatologist – Prof. Sonja Ständer
University of Münster, Münster, Germany 

Patient Advocate – Mrs Collette Thain MBE
PBC Foundation, Edinburgh, UK

This touchPODCAST is for HCPs outside of the UK and USA only.

This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC^® accredited provider.

For further information visit our website: https://touchendocrinologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/

touchMDT – Pruritus in PBC and me: The patient experience – Discussion 1 - touchDERMATOLOGY

touchMDT for touchDERMATOLOGY

Pruritus in PBC and me: The patient experience

Listen to experts Prof. Gideon Hirschfield and Prof. Sonja Ständer, plus patient advocate Mrs Collette Thain MBE, explore the burden of cholestatic pruritus in patients with primary biliary cholangitis (PBC).

The multidisciplinary team and patient advocate:

Hepatologist – Prof. Gideon Hirschfield
University of Toronto, Toronto, Canada

Dermatologist – Prof. Sonja Ständer
University of Münster, Münster, Germany 

Patient Advocate – Mrs Collette Thain MBE
PBC Foundation, Edinburgh, UK

This touchPODCAST is for HCPs outside of the UK and USA only.

This activity is funded by an independent medical education grant from GlaxoSmithKline Research & Development Ltd. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC^® accredited provider.

For further information visit our website: https://touchdermatologyime.org/mdt-cholestatic-pruritus-in-patients-with-pbc/